Skip to main content

transforming growth factor beta receptor 2

The TGFBR2 gene provides instructions for making a protein called transforming growth factor-beta (TGF-β) receptor type 2. This receptor transmits signals from the cell surface into the cell through a process called signal transduction. Through this type of signaling, the environment outside the cell affects activities inside the cell such as stimulation of cell growth and division.

Video picks for Genes
Video library

Normal function

The TGFBR2 gene provides instructions for making a protein called transforming growth factor-beta (TGF-β) receptor type 2. This receptor transmits signals from the cell surface into the cell through a process called signal transduction. Through this type of signaling, the environment outside the cell affects activities inside the cell such as stimulation of cell growth and division.

To carry out its signaling function, the TGF-β receptor type 2 spans the cell membrane, so that one end of the protein projects from the outer surface of the cell (the extracellular domain) and the other end remains inside the cell (the intracellular domain). A protein called TGF-β attaches (binds) to the extracellular domain of the TGF-β receptor type 2, which turns on (activates) the receptor and allows it to bind to another receptor on the cell surface. These three proteins form a complex, which triggers signal transduction by activating other proteins in a signaling pathway called the TGF-β pathway.

Signals transmitted by the TGF-β receptor complex trigger various responses by the cell, including the growth and division (proliferation) of cells, the maturation of cells to carry out specific functions (differentiation), cell movement (motility), and controlled cell death (apoptosis). Because TGF-β receptor type 2 helps prevent cells from growing and dividing too rapidly or in an uncontrolled way, it can suppress the formation of tumours.

Conditions referring to this gene or chromosome

Other names

HNPCC6

MFS2

RIIC

TBR-ii

TBRII

TGF-beta receptor type IIB

TGF-beta type II receptor

TGFbeta-RII

TGFR-2

TGFR2_HUMAN

transforming growth factor beta receptor II

transforming growth factor, beta receptor II (70/80kDa)

Patient picks for Genes

Related patient information and medicines

Oral bronchodilators

Patient information leaflet

Oral bronchodilators

Oral bronchodilators are medicines that are sometimes used to treat breathing problems in people with asthma and other lung-related problems such as chronic obstructive pulmonary disease (COPD). These are beta 2 agonists (salbutamol, bambuterol and terbutaline) and methylxanthines (theophylline and aminophylline). Beta 2 agonists Work by.

High blood pressure in pregnancy

Patient information leaflet

High blood pressure in pregnancy

Medicine to lower the blood pressure may be prescribed for a while. The most commonly used medicine is labetalol. Labetalol - a beta-blocker This may allow your pregnancy to progress further before delivering your baby. The best time to induce the birth (or deliver by caesarean section) varies depending on the factors mentioned above. If you have.

Breast cancer

Patient information leaflet

Breast cancer

These are female hormones. Overall, about 7 in 10 breast cancers are oestrogen receptor positive. Treatment can block the oestrogen in these cancers (see below). Human epidermal growth factor (HER2) is a protein that can affect the growth of some cancer cells. It is found on the surface of normal breast cells. Some breast cancer cells have a very.

Beta-blockers

Patient information leaflet

Beta-blockers

Beta-blockers are medicines that are used to treat a variety of conditions. Their full correct name is beta-adrenoceptor blocking medicines (or beta-adrenergic blocking agents), but they are commonly just called beta-blockers. How do beta-blockers work. Beta-blockers work by blocking the transmission of certain nerve impulses. The ends of some.

Throat cancer

Patient information leaflet

Throat cancer

Other treat... It is a type of monoclonal antibody which means that it can recognise and bind to specific proteins (receptors) that are found in the cancer cells. These proteins are epidermal growth factor receptors (EGFRs) which stimulate the cancer cell to grow and divide. Cetuximab locks on to the EGFR and can prevent the cancer cells from.

Mouth cancer

Patient information leaflet

Mouth cancer

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if yo... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. To.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Mar 2017 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.